Literature DB >> 2479802

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

A Francavilla1, M Barone, S Todo, Q Zeng, K A Porter, T E Starzl.   

Abstract

The immunosuppressive drug, FK 506, increased the regeneration response that follows 40% and 70% hepatectomy in rats. The effect was similar to that obtained with cyclosporin.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2479802      PMCID： PMC2952524          DOI： 10.1016/s0140-6736(89)91853-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  12 in total

1.  Modification of nucleic acid synthesis in regenerating liver by azathioprine.

Authors:  E M Gonzalez; K Krejczy; R A Malt
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

2.  Role of the spleen in regeneration of the liver; an experimental study.

Authors:  R PEREZ-TAMAYO; R ROMERO
Journal:  Lab Invest       Date:  1958 May-Jun       Impact factor: 5.662

3.  EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION.

Authors:  Leonard Makowka; Gregory Svanas; Carlos Esquivel; Raman Venkataramanan; Satoru Todo; Shunzaburo Iwatsuki; David Van Thiel; Thomas E Starzl
Journal:  Surg Forum       Date:  1986

4.  Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse.

Authors:  S Yoshimura; N Kamada
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

5.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

6.  Regeneration and the immune system. I. In vitro and in vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulation.

Authors:  S Miyahara; K Yokomuro; H Takahashi; Y Kimura
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

7.  Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats.

Authors:  Y I Kim; R Y Calne; N Nagasue
Journal:  Surg Gynecol Obstet       Date:  1988-04

8.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

9.  Liver regeneration and lymphocyte activation.

Authors:  A Sakai; R Pfeffermann; S L Kountz
Journal:  Surg Gynecol Obstet       Date:  1976-12

10.  Growth-stimulating factor in regenerating canine liver.

Authors:  T E Starzl; A F Jones; J Terblanche; S Usui; K A Porter; G Mazzoni
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321
View more
  28 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

3.  Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.

Authors:  Qing Lin; Russell N Wesson; Hiromichi Maeda; Yongchun Wang; Zhu Cui; Jun O Liu; Andrew M Cameron; Bin Gao; Robert A Montgomery; George M Williams; Zhaoli Sun
Journal:  J Invest Dermatol       Date:  2014-03-28       Impact factor: 8.551

4.  FK 506 as a growth control factor.

Authors:  A Francavilla; M Barone; T E Starzl; A Zeevi; C Scotti; G Carrieri; V Mazzaferro; J Prelich; S Todo; G Eiras
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

5.  Strategy of FK 506 therapy in liver transplant patients: effect of graft function.

Authors:  K M Abu-Elmagd; J J Fung; M Alessiani; A Jain; S Takaya; R Venkataramanan; V S Warty; W Shannon; S Todo; A Tzakis
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.

Authors:  S Takaya; O Bronsther; S Todo; K Abu-Elmagd; A Jain; M Alessiani; J Madariaga; I R Marino; R Selby; J J Fung
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 7.  The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.

Authors:  A Francavilla; T E Starzl; B Carr; A Azzarone; G Carrieri; Q H Zeng; K A Porter
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  Protective effect of FK 506 against hepatic ischemia in rats.

Authors:  M F Sakr; G M Zetti; H Farghali; T H Hassanein; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

9.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

10.  Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.

Authors:  L Polimeno; A Azzarone; Q H Zeng; C Panella; V Subbotin; B Carr; B Bouzahzah; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.